Amgen Inc (FRA:AMG)
€ 304.75 5.05 (1.69%) Market Cap: 161.98 Bil Enterprise Value: 209.58 Bil PE Ratio: 41.65 PB Ratio: 23.23 GF Score: 91/100

Q1 2020 Amgen Inc Earnings Call Transcript

Apr 30, 2020 / 09:30PM GMT
Release Date Price: €214.6 (-2.12%)
Operator

My name is Ian, and I'll be your conference facilitator today for Amgen's First Quarter 2020 Financial Results Conference Call. (Operator Instructions)

I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.

Arvind Sood
Amgen Inc. - VP of IR

Okay. Thanks, Ian. Good afternoon, everyone. Thanks for joining us for our Q1 call. I hope you and your families are staying safe. We are

(technical difficulty)

with the COVID-19 pandemic. I know I speak on behalf of all my colleagues at Amgen when I say that it's a source of great pride that we work in an industry that can be a part of the solution.

Before we start, I would like to recognize those who are new in their coverage of Amgen, including Tim Anderson of Wolfe Research, Carter Gould of Barclays and Michael Schmidt of Guggenheim. Welcome.

Over the past few weeks, I've talked with many of you, and you have expressed concerns and posed questions about how this COVID pandemic will impact our business, including

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot